HUMORIGIN BIOTECHNOLOGY CORP |
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 4.05 TWD | +3.85% |
|
-22.86% | -.--% |
| 1 day | +3.85% |
| Managers | Title | Age | Since |
|---|---|---|---|
Li Jen Chen
CEO | Chief Executive Officer | - | 13-12-30 |
| Members of the board | Title | Age | Since |
|---|---|---|---|
Zuie Chin Huang
CHM | Chairman | 58 | - |
Li Jen Chen
CEO | Chief Executive Officer | - | 13-12-30 |
Jie Zhang
BRD | Director/Board Member | - | - |
HumOrigin Biotechnology Inc. is a Taiwan-based company principally engaged in the research and development of new drugs. The Companyâs main products include new monoclonal antibody drugs for the immunotherapy of cancers, new anti-influenza drugs and immune cells. The Company also provides related commissioned design services. The Company distributes its products in domestic market and to overseas markets.
| 1st Jan change | Capi. | |
|---|---|---|
| -.--% | 0 | |
| +4.09% | 43.84B | |
| +47.81% | 41.25B | |
| +9.45% | 41.68B | |
| -10.92% | 27.04B | |
| +9.32% | 25.53B | |
| -24.87% | 18.18B | |
| +29.70% | 12.29B | |
| +1.28% | 12.29B | |
| +7.78% | 11.15B |
- Stock Market
- Equities
- 6487 Stock
